メインコンテンツにスキップ
検索

後期臨床

登録

最新のリソース

注目コンテンツ

Upcoming late clinical webinars

Latest late clinical blogs

以下のイベントで弊社のエキスパートをご紹介

All late clinical resources

Controlling Clinical Data from Collection to Submission

AI & Machine Learning, Certara Products, Certara Products - GlobalSubmit, Certara Products - Pinnacle 21, Certara.AI, Data Standards, On-Demand Webinar

FDA Rebuilding After DOGE Cuts: Former Regulators Speak Out

New Approach Methodologies (NAMs), Press Coverage

Minimize risk when preparing for hepatic impairment studies

Certara Products - Simcyp, Clinical Pharmacology, Clinical Trials, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Webinar

PBPK Modeling in Pregnancy: Improving Drug Dosing Without Clinical Trials

Certara Products - Simcyp, Modeling and Simulation - PBPK, Press Coverage

4 key principles of effective pharmacokinetic data reporting

Modeling and Simulation - PK/PD, Blog

Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, On-Demand Webinar

Why CROs should use Pinnacle 21 Enterprise for late phase clinical data validation

サターラの製品 - Pinnacle 21、 臨床データバリデーション、ブログ

Population Pharmacodynamic Modeling of Plozasiran for Treatment of Familial Chylomicronemia Syndrome

Cardiovascular, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

Population Pharmacokinetic Modeling and Exposure-Response Analyses of Nemtabrutinib in Patients With Hematologic Malignancies

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

The one-trial era: what the FDA’s shift signals for the future of drug development

Certara Products - Simcyp, Certara Services, Press Coverage

Understanding quantitative effects of anti-amyloid therapies on tau biomarkers and functional outcome

Certara Products - Certara IQ, Modeling and Simulation, Modeling and Simulation - QSP, Publication
ニュースレターを購読

今すぐ登録：医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。


Powered by Translations.com GlobalLink Web Software